Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion Therapy Combined With Surgery and Radiotherapy for Retroperitoneal Lymph Node Metastases in Gastric Cancer
NCT07007182Phase 2Recruiting
- Start
- Oct 2025
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in gastric adenocarcinoma (2 arms). Primary endpoint: Progression-Free Survival at 2 years. Started Oct 2025; status: recruiting.
02
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT07007182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07007182.